Idéal Investisseur Connexion Connexion
Français English
CAC 40 : Market closed
7 927,75 pts
-1.89%


Last updated : 20/11/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

DBV Technologies share price drops below €1.77, short selling positions increase

The Châtillon-based biotech extends its downward streak mid-session, in a Paris market also oriented lower. The security crosses a technical threshold that has been monitored for several weeks and remains well below its moving averages.


DBV Technologies share price drops below €1.77, short selling positions increase

The €1.77 support level gives way and the share remains below all its moving averages

The share price of DBV Technologies declines by 2.14% to €1.74. During the session, it broke through its support level at €1.77 and remains below it. The share thus stands 15.22% below its 20-day moving average and 43.20% below its 200-day moving average.

The decline reaches 25.28% over one month and 39.53% over three months. The RSI at 30 is at the edge of the oversold zone, which underscores the extent of the recent pullback. The SBF 120 is down 0.77%, but DBV ranks among the most underperforming values in the index, at the bottom of the ranking.

Short positions at 4% of capital, up over 30 days

Declared net short positions reach 4.00% of capital, spread among four funds, according to the declarations reviewed. They have increased by 0.26 percentage points over thirty days, from 3.74%. This level indicates that institutional investors remain positioned to the downside on the security or are seeking to hedge an exposure.

An increase of this magnitude does not signal a sharp reversal, but it aligns with the selling pressure observed for weeks. As a reminder, the company filed its application for biological license with the FDA at the end of September for its peanut allergy patch. When publishing first-half 2026 results on July 16, 2026, it indicated it had cash reserves allowing it to operate until the third quarter of 2027.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Biotechnologies


Context

Period
  • Period: 9M 2026
Key reported figures
  • Revenue: 3,1 millions de dollars
  • Quarterly revenue: 3,1 millions de dollars
  • Revenue growth: -38 %
  • Net income: -162,5 millions de dollars
  • Free cash flow: -159,4 millions de dollars
Risks mentioned
  • Substantial doubt exists about the Company's ability to continue as a going concern within twelve months
  • Manufacturing remediation activities ongoing at Fareva following FDA Warning Letter of April 2026
  • Company requires additional capital to fund operations beyond Q3 2027
Opportunities identified
  • BLA for VIASKIN Peanut Patch in children aged 4-7 years submitted with Priority Review requested, expected FDA determination in Q4 2026
  • Planned BLA submission for toddlers aged 1-3 years in 2027 with potential rolling submission approach
  • Recent $50 million ADS financing completed and $150 million ATM program refreshed to support operations and commercial readiness

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours